Cite

HARVARD Citation

    Perera, N. et al. (2011). Refsum's Disease—Use of the Intestinal Lipase Inhibitor, Orlistat, as a Novel Therapeutic Approach to a Complex Disorder. Journal of obesity. p. . [Online]. 
  
Back to record